Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

This study is a randomized controlled trial evaluating the impact of financial incentives on medication adherence among individuals with schizophrenia, schizoaffective disorder, or bipolar disorder and/or co-occurring substance use disorder who are recently discharged from involuntary hospitalization or are at high risk of future involuntary hospitalization. Participants will be randomized to receive financial incentives for adherence to long-acting injectable medications or to a control group.

NCT Number	NCT07130500
Lead Sponsor	Stanford University Collaborators: University of Pittsburgh Medical Center, Arnold Ventures, Allegheny County Department of Human Services, Pittsburgh Mercy, Stanford Impact Labs, Federal Reserve Bank of New York
Conditions	Schizophrenia Disorder, Schizoaffective Disorder, Bipolar Disorder (BD), Substance Use Disorder (SUD)
Enrollment	1,000 participants
Start Date	2026-03-09
Primary Completion	2029-03 (estimated)
Study Completion	2030-03 (estimated)
Updated on ClinicalTrials.gov	2026-03-27